US 10940168
Method of treating Bruch's membrane hypofunction disease
granted A61KA61K35/616A61K36/258
Quick answer
US patent 10940168 (Method of treating Bruch's membrane hypofunction disease) held by Altregen Co., Ltd. expires Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Altregen Co., Ltd.
- Grant date
- Tue Mar 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K35/616, A61K36/258, A61K9/0048, A61P